Overview

The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma

Status:
RECRUITING
Trial end date:
2025-06-02
Target enrollment:
Participant gender:
Summary
The goal of the study is to learn about the safety and how effective two different strengths of D-MNA compared to a placebo (a look-alike substance that contains no drug) in the treatment of nodular basal cell skin cancer
Phase:
PHASE2
Details
Lead Sponsor:
SkinJect, Inc.